Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01690130 · ClinicalTrials.gov registry record · NA

Transcranial Magnetic Stimulation Effects on Nicotine Craving

A NA study of Nicotine Dependence, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
19
Enrollment target
1
Study location

NCT01690130 is a NA study of Nicotine Dependence that has completed, run by Medical University of South Carolina. The registered enrollment target is 19 participants, below the 186-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01690130, a NA study of Nicotine Dependence, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

The proposed study will measure the change of cortical excitability during nicotine craving and examine the effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on nicotine craving and cue-reactivity among adult regular smokers.

Conditions Studied

Interventions

  • DEVICE Sham Transcranial Magnetic Stimulation
  • DEVICE Transcranial Magnetic Stimulation (Neuronetics)

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2009-06
Est. Completion 2014-02
Phase NA

What the Registry Record Tells You About NCT01690130

The ClinicalTrials.gov registry entry for NCT01690130 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 186-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (90% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 2 interventions - of which Sham Transcranial Magnetic Stimulation is the first listed.

NCT01690130 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT01690130 about?

NCT01690130 is a clinical study titled "Transcranial Magnetic Stimulation Effects on Nicotine Craving". The proposed study will measure the change of cortical excitability during nicotine craving and examine the effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on nicotine craving and cue-reactivity among adult regular smokers.

What is the current status of trial NCT01690130?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2009-06. Estimated completion is 2014-02.

What conditions does trial NCT01690130 study?

This clinical trial studies the following conditions: Nicotine Dependence.

What interventions are being tested in trial NCT01690130?

The interventions under investigation include: Sham Transcranial Magnetic Stimulation (DEVICE), Transcranial Magnetic Stimulation (Neuronetics) (DEVICE).

Who is sponsoring clinical trial NCT01690130?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01690130 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nicotine Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.